» Articles » PMID: 19859562

The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection Against Plasmodium Falciparum Malaria

Overview
Journal PLoS One
Date 2009 Oct 28
PMID 19859562
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antibodies, particularly cytophilic IgG subclasses, with specificity for asexual blood stage antigens of Plasmodium falciparum, are thought to play an important role in acquired immunity to malaria. Evaluating such responses in longitudinal sero-epidemiological field studies, allied to increasing knowledge of the immunological mechanisms associated with anti-malarial protection, will help in the development of malaria vaccines.

Methods And Findings: We conducted a 1-year follow-up study of 305 Senegalese children and identified those resistant or susceptible to malaria. In retrospective analyses we then compared post-follow-up IgG responses to six asexual-stage candidate malaria vaccine antigens in groups of individuals with clearly defined clinical and parasitological histories of infection with P. falciparum. In age-adjusted analyses, children resistant to malaria as well as to high-density parasitemia, had significantly higher IgG1 responses to GLURP and IgG3 responses to MSP2 than their susceptible counterparts. Among those resistant to malaria, high anti-MSP1 IgG1 levels were associated with protection against high-density parasitemia. To assess functional attributes, we used an in vitro parasite growth inhibition assay with purified IgG. Samples from individuals with high levels of IgG directed to MSP1, MSP2 and AMA1 gave the strongest parasite growth inhibition, but a marked age-related decline was observed in these effects.

Conclusion: Our data are consistent with the idea that protection against P. falciparum malaria in children depends on acquisition of a constellation of appropriate, functionally active IgG subclass responses directed to multiple asexual stage antigens. Our results suggest at least two distinct mechanisms via which antibodies may exert protective effects. Although declining with age, the growth inhibitory effects of purified IgG measurable in vitro reflected levels of anti-AMA1, -MSP1 and -MSP2, but not of anti-GLURP IgG. The latter could act on parasite growth via indirect parasiticidal pathways.

Citing Articles

The impact of intermittent preventive treatment in school aged children with dihydroartemisinin piperaquine and artesunate amodiaquine on IgG response against six blood stage Plasmodium falciparum antigens.

Lyimo E, Makenga G, Turner L, Lavstsen T, Lusingu J, Van Geertruyden J PLoS One. 2025; 20(1):e0316482.

PMID: 39883707 PMC: 11781616. DOI: 10.1371/journal.pone.0316482.


Infection with soil-transmitted helminths and their impact on coinfections.

Schlosser-Brandenburg J, Midha A, Mugo R, Ndombi E, Gachara G, Njomo D Front Parasitol. 2025; 2():1197956.

PMID: 39816832 PMC: 11731630. DOI: 10.3389/fpara.2023.1197956.


IgG and IgM responses to the Plasmodium falciparum asexual stage antigens reflect respectively protection against malaria during pregnancy and infanthood.

Gbaguidi M, Adamou R, Edslev S, Hansen A, Domingo N, Dechavanne C Malar J. 2024; 23(1):154.

PMID: 38764069 PMC: 11103834. DOI: 10.1186/s12936-024-04970-7.


IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length Merozoite Surface Protein 1 (MSP1).

Rathay V, Furle K, Kiehl V, Ulmer A, Lanzer M, Thomson-Luque R Vaccines (Basel). 2024; 12(2).

PMID: 38400191 PMC: 10893298. DOI: 10.3390/vaccines12020208.


B-Cell Epitope Mapping of the Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon.

Baptista B, Souza A, Oliveira L, de Souza H, de Barros J, de Queiroz L Vaccines (Basel). 2023; 11(2).

PMID: 36851323 PMC: 9966924. DOI: 10.3390/vaccines11020446.


References
1.
Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P . Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med. 1995; 182(2):409-18. PMC: 2192140. DOI: 10.1084/jem.182.2.409. View

2.
Aidoo M, Terlouw D, Kolczak M, McElroy P, Kuile F, Kariuki S . Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet. 2002; 359(9314):1311-2. DOI: 10.1016/S0140-6736(02)08273-9. View

3.
Marsh K, Otoo L, Hayes R, Carson D, Greenwood B . Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg. 1989; 83(3):293-303. DOI: 10.1016/0035-9203(89)90478-1. View

4.
Iriemenam N, Khirelsied A, Nasr A, ElGhazali G, Giha H, Elhassan A-Elgadir T . Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. Vaccine. 2008; 27(1):62-71. DOI: 10.1016/j.vaccine.2008.10.025. View

5.
Okech B, Corran P, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang T . Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun. 2004; 72(3):1557-67. PMC: 356041. DOI: 10.1128/IAI.72.3.1557-1567.2004. View